Table 3.
Hemodynamics Factors Over Time in the Non-Survival and Survival Groups
| Pmsf (mmHg) | Pmsf-CVP (mmHg) | RVr (Ω) | CVP (mmHg) | CO (L/min) | MAP (mmHg) | Lac (mmol/L) | ||
|---|---|---|---|---|---|---|---|---|
| Non-survival group | 0h | 15.77±2.97 | 6.21±0.86 | 1.62±0.36 | 9.56±3.12 | 4.07±1.39 | 77.56±10.18 | 5.01±2.38 |
| T1 | 16.08±2.77 | 5.30±1.34 | 1.63±0.48 | 10.78±2.68 | 3.48±1.27 | 77.00±11.09 | 6.46±2.25 | |
| T2 | 16.11±2.74 | 5.44±0.92 | 1.77±0.45 | 10.67±3.04 | 3.33±1.36 | 75.56±8.60 | 4.60±1.57 | |
| T3 | 15.12±1.56 | 5.45±1.15 | 1.74±0.36 | 9.67±2.17 | 3.32±1.22 | 74.44±11.80 | 3.31±1.80 | |
| 24h | 16.15±3.27 | 5.60±1.08 | 1.75±0.50 | 10.56±4.06 | 3.51±1.39 | 75±8.68 | 4.12±3.90 | |
| Survival group | 0h | 12.69±7.13 | 5.1±2.73 | 1.41±0.37 | 10.12±2.92 | 4.97±1.61 | 88.55±12.78 | 3.10±1.97 |
| T1 | 11.48±7.11 | 6.10±1.52 | 1.37±0.31 | 9.21±3.08 | 4.68±1.26 | 81.45±10.11 | 2.94±1.88 | |
| T2 | 12.63±6.22 | 6.04±1.33 | 1.39±0.29 | 8.72±3.63 | 4.49±1.57 | 79.83±15.46 | 3.08±2.37 | |
| T3 | 12.36±5.62 | 6.14±0.95 | 1.45±0.27 | 7.97±3.44 | 4.32±1.28 | 82.03±14.35 | 2.62±1.6 | |
| 24h | 10.6±7.26 | 6.22±3.92 | 1.44±0.27 | 7.67±3.28 | 4.71±4.74 | 77.68±13.69 | 2.17±1.31 | |
| Total analysis | HF | 0.732 | 0.649 | 0.854 | 0.719 | 0.302 | 0.497 | 0.739 |
| Group | F, P | 6.006,0.016* | 0.755,0.388 | 5.611,0.022* | 5.390,0.024* | 3.073,0.086 | 2.122,0.151 | 2.489,0.124 |
| Time | F, P | 0.195,0.887 | 0.409,0.709 | 2.299,0.078 | 1.914,0.137 | 0.561,0.484 | 2.433,0.096 | 4.080,0.013* |
| Time*group | F, P | 0.410,0.731 | 0.249,0.825 | 1.047,0.375 | 3.623,0.019* | 0.084,0.800 | 1.145,0.320 | 1.584,0.204 |
Notes: Values are expressed as means ± standard deviation.* indicates significance (P <0.05).HF, Huynh-Feldt; t1-t3 every 4–9 h from 0h to 24h after admission.
Abbreviations: Pmsf, mean systemic filling pressure; CVP, central venous pressure; Pmsf−CVP, difference between Pmsf and CVP; RVr, resistance to venous return; CO cardiac output; MAP, mean arterial pressure; Lac, lactate.